Cargando…
Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort
(1) Background: The link between diabetes and hypertension is mutual and reciprocal, increasing the risks for the development of atrial fibrillation (AF). The main objective was to develop a prediction model for AF in a population with both diabetes and hypertension at five years of follow-up. (2) M...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277633/ https://www.ncbi.nlm.nih.gov/pubmed/32429492 http://dx.doi.org/10.3390/ijerph17103491 |
_version_ | 1783543163849277440 |
---|---|
author | Muria-Subirats, Eulalia Clua-Espuny, Josep Lluis Ballesta-Ors, Juan Lorman-Carbo, Blanca Lechuga-Duran, Iñigo Fernández-Saez, Jose Pla-Farnos, Roger |
author_facet | Muria-Subirats, Eulalia Clua-Espuny, Josep Lluis Ballesta-Ors, Juan Lorman-Carbo, Blanca Lechuga-Duran, Iñigo Fernández-Saez, Jose Pla-Farnos, Roger |
author_sort | Muria-Subirats, Eulalia |
collection | PubMed |
description | (1) Background: The link between diabetes and hypertension is mutual and reciprocal, increasing the risks for the development of atrial fibrillation (AF). The main objective was to develop a prediction model for AF in a population with both diabetes and hypertension at five years of follow-up. (2) Methods: A multicenter and community-based cohort study was undertaken of 8237 hypertensive diabetic patients without AF between 1 January 2103 and 31 December 2017. Multivariate Cox proportional-hazards regression models were used to identify predictors AF and to stratify risk scores by quartiles. (3) Results: AF incidence was 10.5/1000 people/years (95% confidence interval (CI) 9.5–11.5), higher in men. The independent prognostic factors identified: age (hazard ratio (HR) 1.07 95% CI 1.05–1.09, p < 0.001), weight (HR 1.03 95% CI 1.02–1.04, p < 0.001), CHA(2)DS(2)VASc score (HR 1.57 95% CI 1.16–2.13, p = 0.003) and female gender (HR 0.55 95% CI 0.37–0.82, p = 0.004). Q4 (highest-risk group for AF) had the highest AF incidence, stroke and mortality, and the smallest number needed to screen to detect one case of AF. (4) Conclusions: Risk-based screening for AF should be used in high cardiovascular risk patients as the hypertensive diabetics, for treatment of modifiable cardiovascular risk, and monitoring AF detection. |
format | Online Article Text |
id | pubmed-7277633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72776332020-06-12 Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort Muria-Subirats, Eulalia Clua-Espuny, Josep Lluis Ballesta-Ors, Juan Lorman-Carbo, Blanca Lechuga-Duran, Iñigo Fernández-Saez, Jose Pla-Farnos, Roger Int J Environ Res Public Health Article (1) Background: The link between diabetes and hypertension is mutual and reciprocal, increasing the risks for the development of atrial fibrillation (AF). The main objective was to develop a prediction model for AF in a population with both diabetes and hypertension at five years of follow-up. (2) Methods: A multicenter and community-based cohort study was undertaken of 8237 hypertensive diabetic patients without AF between 1 January 2103 and 31 December 2017. Multivariate Cox proportional-hazards regression models were used to identify predictors AF and to stratify risk scores by quartiles. (3) Results: AF incidence was 10.5/1000 people/years (95% confidence interval (CI) 9.5–11.5), higher in men. The independent prognostic factors identified: age (hazard ratio (HR) 1.07 95% CI 1.05–1.09, p < 0.001), weight (HR 1.03 95% CI 1.02–1.04, p < 0.001), CHA(2)DS(2)VASc score (HR 1.57 95% CI 1.16–2.13, p = 0.003) and female gender (HR 0.55 95% CI 0.37–0.82, p = 0.004). Q4 (highest-risk group for AF) had the highest AF incidence, stroke and mortality, and the smallest number needed to screen to detect one case of AF. (4) Conclusions: Risk-based screening for AF should be used in high cardiovascular risk patients as the hypertensive diabetics, for treatment of modifiable cardiovascular risk, and monitoring AF detection. MDPI 2020-05-16 2020-05 /pmc/articles/PMC7277633/ /pubmed/32429492 http://dx.doi.org/10.3390/ijerph17103491 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Muria-Subirats, Eulalia Clua-Espuny, Josep Lluis Ballesta-Ors, Juan Lorman-Carbo, Blanca Lechuga-Duran, Iñigo Fernández-Saez, Jose Pla-Farnos, Roger Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort |
title | Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort |
title_full | Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort |
title_fullStr | Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort |
title_full_unstemmed | Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort |
title_short | Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort |
title_sort | incidence and risk assessment for atrial fibrillation at 5 years: hypertensive diabetic cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277633/ https://www.ncbi.nlm.nih.gov/pubmed/32429492 http://dx.doi.org/10.3390/ijerph17103491 |
work_keys_str_mv | AT muriasubiratseulalia incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort AT cluaespunyjoseplluis incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort AT ballestaorsjuan incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort AT lormancarboblanca incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort AT lechugaduraninigo incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort AT fernandezsaezjose incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort AT plafarnosroger incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort AT incidenceandriskassessmentforatrialfibrillationat5yearshypertensivediabeticcohort |